Price T Rowe Associates Inc Neogenomics Inc Transaction History

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 91,574 shares of NEO stock, worth $996,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,574
Previous 432,540 78.83%
Holding current value
$996,325
Previous $6.38 Million 76.34%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$13.0 - $18.43 $4.43 Million - $6.28 Million
-340,966 Reduced 78.83%
91,574 $1.51 Million
Q3 2024

Nov 14, 2024
SELL
$13.4 - $17.73 $2.09 Million - $2.77 Million
-156,054 Reduced 26.51%
432,540 $6.38 Million
Q2 2024

Aug 14, 2024
SELL
$13.01 - $15.77 $740,242 - $897,281
-56,898 Reduced 8.81%
588,594 $8.16 Million
Q1 2024

May 15, 2024
BUY
$14.06 - $16.79 $63,663 - $76,025
4,528 Added 0.71%
645,492 $10.1 Million
Q4 2023

Feb 14, 2024
BUY
$11.67 - $20.73 $548,104 - $973,625
46,967 Added 7.91%
640,964 $10.4 Million
Q3 2023

Nov 14, 2023
BUY
$12.15 - $17.85 $137,404 - $201,865
11,309 Added 1.94%
593,997 $7.31 Million
Q2 2023

Aug 14, 2023
BUY
$14.1 - $19.83 $3.57 Million - $5.02 Million
252,988 Added 76.73%
582,688 $9.37 Million
Q1 2023

May 15, 2023
BUY
$9.09 - $19.45 $12,344 - $26,413
1,358 Added 0.41%
329,700 $5.74 Million
Q4 2022

Feb 14, 2023
SELL
$6.45 - $12.07 $2.58 Million - $4.82 Million
-399,246 Reduced 54.87%
328,342 $3.03 Million
Q3 2022

Nov 14, 2022
SELL
$7.86 - $12.91 $6.64 Million - $10.9 Million
-844,425 Reduced 53.72%
727,588 $6.27 Million
Q2 2022

Aug 15, 2022
BUY
$7.06 - $13.97 $35,836 - $70,911
5,076 Added 0.32%
1,572,013 $12.8 Million
Q1 2022

May 16, 2022
BUY
$12.15 - $35.28 $202,358 - $587,588
16,655 Added 1.07%
1,566,937 $19 Million
Q4 2021

Feb 14, 2022
SELL
$30.49 - $48.49 $37,197 - $59,157
-1,220 Reduced 0.08%
1,550,282 $52.9 Million
Q3 2021

Nov 15, 2021
SELL
$41.66 - $52.52 $314,324 - $396,263
-7,545 Reduced 0.48%
1,551,502 $74.8 Million
Q2 2021

Aug 16, 2021
BUY
$36.62 - $51.69 $249,418 - $352,060
6,811 Added 0.44%
1,559,047 $70.4 Million
Q1 2021

May 17, 2021
BUY
$41.56 - $59.88 $7.89 Million - $11.4 Million
189,930 Added 13.94%
1,552,236 $74.9 Million
Q4 2020

Feb 16, 2021
BUY
$36.08 - $56.47 $49.2 Million - $76.9 Million
1,362,306 New
1,362,306 $73.3 Million

Others Institutions Holding NEO

# of Institutions
282
Shares Held
124M
Call Options Held
751K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.37B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email